Hosted on MSN
MapLight’s ML-004 autism extension study: What ongoing safety data mean for investors
MapLight Therapeutics, Inc. (MPLT) announced an update on their ongoing clinical study. Study Overview MapLight Therapeutics is running an extension study called “An Open-label Extension Study to ...
A major extension to the Autism Spectrum Disorder (ASD) hub, Ostia, at Good Counsel College in New Ross has been given the green light. The development will include two additional specialist ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results